News

Results from the first study (Study 201), a Phase IIa dose-escalation trial involving 28 patients, demonstrated that INCB18424 was well tolerated at all doses and significantly improved overall

Ms Pecota has previously served as CFO for NuGEN Technologies, a life sciences tools company. Prior to that Ms Pecota served as a financial consultant to early- and

The first patent covers laser tips that can be configured to direct energy in multiple directions including to the sides, away from the handpiece. This patent relates not

Dr Bostian joins Kemin from Mpex Pharmaceuticals, where he served as chief scientific officer and innovator of the company’s R&D platform. Dr Bostian is expected to add significant

The sub-group analysis was designed to determine whether interrupting Humira treatment would affect efficacy in psoriasis patients who had already achieved good response to Humira. After 33 weeks,

The European Commission’s decision was adopted following the favorable opinion issued by the European Medicine Agency Committee of Orphan Medicinal Products. The designation was granted to Triskel EU

Promius Pharma, which will initially focus on the branded dermatology market, is said to be based on a platform of strategic licensing initiatives and internal product development activities

The agreement is for the development of a marketed protein to be delivered using Flamel’s Medusa technology. Flamel is also receiving additional revenues from Wyeth for work being

The goal of the collaboration is to develop a series of genetic tests that will help physicians better understand an individual’s inherited resistance to weight loss and, more